arXiv · 2009.08405
Bayesian Matrix Completion for Hypothesis Testing
Abstract
We aim to infer bioactivity of each chemical by assay endpoint combination, addressing sparsity of toxicology data. We propose a Bayesian hierarchical framework which borrows information across different chemicals and assay endpoints, facilitates out-of-sample prediction of activity for chemicals not yet assayed, quantifies uncertainty of predicted activity, and adjusts for multiplicity in hypothesis testing. Furthermore, this paper makes a novel attempt in toxicology to simultaneously model heteroscedastic errors and a nonparametric mean function, leading to a broader definition of activity whose need has been suggested by toxicologists. Real application identifies chemicals most likely active for neurodevelopmental disorders and obesity.
Explore related subjects
Keep this discovery
Bora Jin, David B. Dunson, Julia E. Rager, David Reif, Stephanie M. Engel, Amy H. Herring. 2020-09-17. Bayesian Matrix Completion for Hypothesis Testing. https://arxiv.org/abs/2009.08405
Cite the original work for its findings. Save a collection to share your selection of sources.